Survie globale des patients traités par greffe de cellules souches hématopoïétiques (CSH) autologue pour maladie auto-immune (MAI) sévère : analyse de l’activité en France depuis 1997
Perrine Guillaume-Jugnot(Aix-Marseille Université), Dominique Farge(Hôpital Saint-Louis), G. Pugnet(Hôpital Rangueil), Chengchen Wu(Hôpital Saint-Louis), Ibrahim Yakoub‐Agha(Inserm), Louis Terriou(Centre Hospitalier Universitaire de Lille), Manuela Badoglio(Sorbonne Université), Emmanuel Chatelus(Laboratoire National de Référence), A. Hij(Hôpital Saint-Louis), Thierry Martin(Western Infirmary), Zora Marjanovic(Sorbonne Université), Bruno Lioure
Cited by 0
Related Papers
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2016|538
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
|New England Journal of Medicine|2007|520
Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
|Seminars in Arthritis and Rheumatism|2007|456
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432